Skip to content

Testing of the Cancer Thriving and Surviving Breast Cancer Program

Co-creating and Testing the Reach and Effectiveness of an Integrated Peer-to-peer Self-management Program for Breast Cancer Survivors: a Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03651921
Acronym
COSS
Enrollment
39
Registered
2018-08-29
Start date
2017-12-12
Completion date
2019-08-15
Last updated
2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm, Cancer Survivorship, Early-Stage Breast Cancer, Intervention, Self-Management

Keywords

Breast Cancer, Self-Management, Cancer Survivorship

Brief summary

The adjusted Cancer Thriving and Surviving Program (CTS) for women with breast cancer living in Switzerland (CTS-BC-CH) is a course of 7 weekly sessions of 2.5 - 3 hours led by trained peer-leaders (women with breast cancer experience). This pilot study aims to explore the reach of the CTS-BC-CH program (integrated into the clinical pathway) and to investigate its preliminary effectiveness with regard to Swiss breast cancer patients' self-efficacy and self-management.

Detailed description

In 2016/17, the self-management program for cancer survivors, the Cancer Thriving and Surviving Program (CTS) was translated into German. The content of the CTS was adapted to breast cancer specific needs in three interdisciplinary workshops based on a participatory approach including active patient engagement. Additional disease-specific topics were developed and confirmed applying a multi-stakeholder e-rating approach. After a consensus meeting with the participation of breast cancer survivors, health care professional and international experts in the field of self-management, consensus on the program was reached in June 2017, resulting in the CTS-BC-CH program, i.e. a standardized manual for course leaders. This pilot study aims to explore the reach of the CTS-BC-CH program (integrated into the clinical pathway) and to investigate its preliminary effectiveness for female Swiss breast cancer patients. The CTS-BC-CH is delivered in two breast cancer centers in in the German-speaking part of Switzerland as a group-based program with seven weekly sessions of 2.5 - 3 hours led by trained peer-leaders. Course leaders have to complete a 4-days training provided by certified master trainers. First, participants are enrolled for usual care, followed by participants who will attend the CTS-BC-CH course. Participants will complete self-reported questionnaires at three time points over a period of 6 months.

Interventions

BEHAVIORALCTS-BC-CH

CTS-BC-CH is a standardized program with 7 weekly group sessions (2.5. to 3 hours). The CTS-BC-CH focuses on building skills, sharing experiences, and support among the participants. Program elements are: Brainstorming, action plan formulation, action plan feedback, problem solving, and decision making.

Sponsors

Swiss Cancer League
CollaboratorOTHER
Lindenhofgruppe AG
CollaboratorINDUSTRY
Manuela Eicher
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion breast cancer patients * female gender * written informed consent * aged 18 years or older * diagnosed with an early stage breast cancer (stage 0, stage I, stage IIA, stage IIB, and stage IIIA breast cancers) * completed primary therapy (i. e. surgery, chemotherapy and/or radiation therapy) * at the beginning of follow-up care (including long-term endocrine therapy or targeted therapy) * free of recurrence * mentally able to participate, assessment of the psychological state performed by the responsible psychologist/psycho-oncologist in the breast center * treated in the participating breast center Inclusion course leaders * female gender * written informed consent * aged 18 years or older * diagnosed with an early stage breast cancer (stage 0, stage I, stage IIA, stage IIB, and stage IIIA breast cancers) * \> than 2 years post diagnosis * free of recurrence * mentally able to participate, assessment of the psychological state performed by the responsible psychologist/psycho-oncologist in the breast center * treated in the participating breast center * willing to participate in a course leaders training Exclusion breast cancer patients and course leaders * participation in another psycho-social intervention study * known illiteracy (reading and writing difficulties) * lack of language proficiency (German) Inclusion breast care nurses for CTS-BC-CH implementation * female gender * employed at breast care center \> 1 year * participation in 4-days CTS-BC-CH course leader training Inclusion breast care nurses for evaluating self-management support practices * nurses: graduated with a nurses diploma \> 1 year of breast cancer care experience

Design outcomes

Primary

MeasureTime frameDescription
Reach of intervention assessed by ratio of eligible patients vs. participating patients21 weeks after baseline
Changes in self-management skills assessed by heiQChange from baseline to 20 weeks after baselineAssessed by the Health Education Impact Questionnaire (heiQ)

Secondary

MeasureTime frameDescription
Change in patient-reported symptom burden assessed by BCPT Symptom ScalesChange from baseline to 20 weeks after baselineAssessed by the Breast Cancer Prevention Trial (BCPT) Symptom Scales
Change in patient-reported self-efficacy assessed by SES6GChange from baseline to 20 weeks after baselineAssessed by the Self-Efficacy for Managing Chronic Disease Scale (SES6G)
Change in nurse-reported self-efficacy and self-management support practices assessed by SEPSSChange from baseline to 30 weeks after baselineAssessed by the Self-Efficacy and Performance in Self-management Support (SEPSS) measure
Change in patient-reported health service navigation assessed by heiQChange from baseline to 20 weeks after baselineAssessed by a subscale of the Health Education Impact Questionnaire (heiQ)
Change in patient-reported health literacy assessed by HLS-EU-Q6Change from baseline to 20 weeks after baselineAssessed by the Health Literacy Scale Europe (HLS-EU-Q6)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026